Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Medical Oncology
•
Hematology
•
Sickle Cell
In an adult sickle cell patient who is found on brain imaging to have a lacunar infarct do you recommend initiating routine exchange transfusions, and if yes, for how long?
Related Questions
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
How would you approach IgM kappa MGUS paraproteinemia with a rising free light chain ratio?
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
Would you use the MIPSS-PV risk scoring to decide in decision making for cytoreductive therapy in PV?
How would you treat an elderly newly diagnosed tDLBCL that has previously seen R-CHOP and Bendamustine-Obinutuzumab prior to the transformative event?
Is there an advantage to early therapy with hypomethylating agents for high/very high risk patients with MDS who are not transplant candidates and have only mild cytopenias?
How would you manage a patient with p53 mutated MCL who has progressed after a BTKi and CAR-T with a CD20 negative clone?
How do you treat R/R T cell Histiocyte rich large b cell lymphoma?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?